Evidence map›Paper›PMID 36210154›Full record

ReviewCurrent topics in membranes2022

Transient receptor potential vanilloid type 4 (TRPV4) in urinary bladder structure and function.

Megan Elizabeth Perkins, Margaret A Vizzard

Open access · greenAbstract readReview
In one paragraph

Review in Current topics in membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Megan Elizabeth PerkinsDepartment of Neurological Sciences, The Larner College of Medicine, The University of Vermont, Burlington, VT, United States.
Margaret A VizzardDepartment of Neurological Sciences, The Larner College of Medicine, The University of Vermont, Burlington, VT, United States. Electronic address: margaret.vizzard@uvm.edu.
University of Vermont · US

Funding

Role of proNGF-p75 signaling in the bladder control after spinal cord injuryR01DK120108 · NIDDK · OHIO STATE UNIVERSITY · PI GAO, JIE, VIZZARD, MARGARET ANN · 2019 to 2023
$2.6M
Cystitis-induced bladder dysfunction and painR01DK124580 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2021 to 2024
$2.1M
NIDDK NIH HHS R01 DK120108NIDDK NIH HHS R01 DK124580
6 · The paper itself

Abstract

Bladder pain syndrome (BPS)/interstitial cystitis (IC) is a urologic, chronic pelvic pain syndrome characterized by pelvic pain, pressure, or discomfort with urinary symptoms. Symptom exacerbation (flare) is common with multiple, perceived triggers including stress. Multiple transient receptor potential (TRP) channels (TRPA1, TRPV1, TRPV4) expressed in the bladder have specific tissue distributions in the lower urinary tract (LUT) and are implicated in bladder disorders including overactive bladder (OAB) and BPS/IC. TRPV4 channels are strong candidates for mechanosensors in the urinary bladder and TRPV4 antagonists are promising therapeutic agents for OAB. In this perspective piece, we address the current knowledge of TRPV4 distribution and function in the LUT and its plasticity with injury or disease with an emphasis on BPS/IC. We review our studies that extend the knowledge of TRPV4 in urinary bladder function by focusing on (i) TRPV4 involvement in voiding dysfunction, pelvic pain, and non-voiding bladder contractions in NGF-OE mice; (ii) distention-induced luminal ATP release mechanisms and (iii) involvement of TRPV4 and vesicular release mechanisms. Finally, we review our lamina propria studies in postnatal rat studies that demonstrate: (i) the predominance of the TRPV4+ and PDGFRα+ lamina propria cellular network in early postnatal rats; (ii) the ability of exogenous mediators (i.e., ATP, TRPV4 agonist) to activate and increase the number of lamina propria cells exhibiting active Ca

Indexed as

Transient Receptor Potential ChannelsUrinary Bladder, OveractiveAdenosine TriphosphateAnimalsMiceNerve Growth FactorPelvic PainRatsReceptor, Platelet-Derived Growth Factor alphaTRPV Cation ChannelsUrinary BladderAdenosine TriphosphateNerve Growth FactorReceptor, Platelet-Derived Growth Factor alphaTransient Receptor Potential ChannelsTrpv4 protein, mouseTrpv4 protein, ratTRPV Cation ChannelsCa(2+) eventsLamina propriaPainful bladder syndromeSyncytiumUrothelium

Identifiers

PMID36210154
PMCPMC10486315
OpenAlexW4285742098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.